HSBC Holdings Plc lost its role on the initial public offering of Stada Arzneimittel AG, according to people familiar with ...

Baird analysts revised their stance on CrowdStrike Holdings (NASDAQ:CRWD) stock, downgrading it from Outperform to Neutral. This adjustment comes despite an increase in the price target from $390.00 ...

1 Day BDMD 16.10% DJIA 0.92% Russell 2K 0.47% Health Care/Life Sciences -0.58% ...

Goldman Sachs announced a leadership reshuffle this week that created a new layer of management for its all-important investment bank. As part of the reshuffle, Goldman tapped three of its most ...

Tuesday, analysts at Baird increased their price target on Take-Two Interactive (NASDAQ:TTWO) shares to $210 from the previous $181, while reaffirming an Outperform rating on the stock. The revision ...

NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Baird Medical (TASE:PMCN) (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored... ByInvesting.com • 13 Jan ...

was $540 now $319 for your first year Make up your own mind. Build robust opinions on the FT's trusted journalism. Offer available until 27 February 2025.

Some firms also said they have revised down their outlook for sales, investment and hiring ... About three-quarters of businesses expect inflation to be within the Bank’s target range of 1% to 3% over ...

NEW YORK, Jan. 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA ...

including biotech and medical stocks reports on trading and news for Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology.